EMvision Medical Devices Ltd.ASX: EMV

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by EMvision Medical Devices Ltd. via ASX

Filed with ASX ·

26/10/2026 EMVision Medical Devices Ltd ACN 620 388 230 Suite 4.01, 65 Epping Rd Sydney NSW 2113 02 8667 5337 contact@emvision.com.au APPENDIX 4C – 30 SEPTEMBER 2026 QUARTERLY ACTIVITIES & CASHFLOW REPORT Highlights • By early October, the Pivotal (Validation) trial surpassed 230 patients...

View Attachment

6ix is reading this filing.

EMvision Medical Devices Ltd. on 6ix

Earlier from EMvision Medical Devices

All EMvision Medical Devices news releases